The Hodgkin-Huxley formulation, at its 60th anniversary, remains a bastion of neuroscience. Sodium channels Nav1.1-Nav1.3 and Nav1.6-Nav1.9 support electrogenesis in neurons and are often considered ''neuronal,'' whereas Nav1.4 and Nav1.5 drive electrogenesis in skeletal and cardiac muscle. These channels are, however, expressed in cell types that are not considered electrically excitable. Here, we discuss sodium channel expression in diverse nonexcitable cell types, including astrocytes, NG2 cells, microglia, macrophages, and cancer cells, and review evidence of noncanonical roles, including regulation of effector functions such as phagocytosis, motility, Na + /K + -ATPase activity, and metastatic activity. Armed with powerful techniques for monitoring channel activity and for real-time assessment of [Na + ] i and [Ca 2+ ] i , neuroscientists are poised to expand the understanding of noncanonical roles of sodium channels in healthy and diseased tissues.
In Brief Sodium channels support electrogenesis in neurons and skeletal and cardiac muscle. They are, however, expressed in cell types that are not considered electrically excitable, including astrocytes, NG2 cells, microglia, macrophages, and cancer cells, where they regulate phagocytosis, motility, Na + /K + -ATPase activity, and metastatic activity.
We have now passed the 60 th anniversary of the Hodgkin and Huxley (1952) discovery of the role of sodium channels in electrogenesis, and it remains a bastion of modern neuroscience: voltage-gated sodium channels are major players in actionpotential electrogenesis. Seven of the voltage-gated sodium channels (Nav1.1-Nav1.3 and Nav1.6-Nav1.9) play major roles in electrogenesis in neurons and are often considered ''neuronal,'' whereas Nav1.4 is the muscle sodium channel and Nav1.5 is the predominant cardiac myocyte channel. The canonical role of sodium channels in impulse electrogenesis and conduction in these excitable cells has been well established and is relatively well understood (see Rush et al., 2007; Catterall, 2012) . Indeed, major aspects of the pathophysiology of neurological disorders, including epilepsy Helbig et al., 2008; Reid et al., 2009; Eijkelkamp et al., 2012; Oliva et al., 2012) , multiple sclerosis (MS) (Waxman, 2006) , peripheral neuropathy (Faber et al., 2012a (Faber et al., ,2012b , neuropathic pain (Wood, 2007; Dib-Hajj et al., 2010 , muscle diseases such as myotonic dystrophy (Jurkat-Rott et al., 2010; Stunnenberg et al., 2010) and periodic paralysis (Cannon 2010) , and cardiac disorders such as Brugada syndrome (Campuzano et al., 2010; Song and Shou, 2012; Tarradas et al., 2013) , can be attributed to abnormalities of electrical excitability due to sodium channel dysfunction. Nonetheless, beyond the expression of sodium channels in neurons, myocytes, cardiomyocytes, and other excitable cells, there is convincing evidence that multiple subtypes of voltage-gated sodium channels-the same channels that support electrogenesis in nerve cells, muscle cells, and cardiac myocytes-are expressed and play major functional roles in cell types that have been traditionally considered to be nonexcitable (termed here ''nonexcitable cells''). Moreover, there is abundant evidence demonstrating that sodium channels participate in or regulate multiple effector functions in these nonexcitable cells. It is becoming clear, for example, that sodium channels-located not only on the plasma membrane delimiting the cell from the extracellular space but also, in some cases, on intracellular membranes surrounding specific organelles within the cell-contribute to processes as diverse as phagocytosis, motility, the release of bioactive molecules, and the regulation of Na + /K + -ATPase activity in nonneuronal cells, including cells as disparate as microglia and astrocytes within the CNS, where they participate in the response to CNS injury, and cancer cells, where they contribute to motility and invasiveness. The neuroscience community, which has a long history of discoveries on sodium channels and their function and which possesses an armamentarium of powerful tools that can help explicate the function of sodium channels, is in a unique position to elucidate the functions of sodium channels in nonexcitable cells, as well as in neurons. In this article, we discuss the expression of sodium channels in nonexcitable cells and review accumulating evidence showing that, within these cells, these channels play noncanonical roles and participate in multiple, diverse effector functions.
Sodium Channels Are Expressed in Nonexcitable Cells
It is now known that nine different genes encode nine distinct sodium channels (Nav1.1-Nav1.9), which are expressed with diverse temporal and regional patterns in excitable cells (Catterall et al., 2005) and are variably associated with b-subunits (Patino and Isom, 2010; Brackenbury and Isom, 2011) . Although all voltage-gated sodium channels share a common overall structural motif and considerable homology, the different subtypes display distinct voltage dependence and kinetic and pharmacological properties (Catterall et al., 2005) , and the repertoire of sodium channel subtypes expressed in a particular type of excitable cell significantly contributes to its pattern of electroresponsiveness (see, e.g., Waxman 2000; Rush et al., 2007) .
Nav1.1, Nav1.2, and Nav1.6 are expressed in both central and peripheral neurons, whereas Nav1.7-Nav1.9 are preferentially expressed in peripheral neurons (Beckh et al., 1989; Felts et al., 1997; Gong et al., 1999; Schaller and Caldwell, 2003; Catterall et al., 2005; Dib-Hajj et al., 2013) . Nav1.3 is present in the adult human brain Whitaker et al., 2001; Thimmapaya et al., 2005) , but it is predominantly expressed during embryonic and early postnatal periods in rodents. Nav1.3 is upregulated in dorsal root ganglion neurons in adult rodents after nerve injury Black et al., 1999) and contributes to hyperexcitability of these cells and thus neuropathic pain (Cummins and Waxman, 1997; Samad et al., 2013) . Nav1.4 is predominantly expressed in skeletal muscle (Barchi et al., 1984; Trimmer et al., 1989) , whereas Nav1.5 is the principal sodium channel in cardiac muscle (Gellens et al., 1992; Clancy and Kass 2002; Fozzard 2002) . Early evidence of voltage-dependent sodium currents attributable to sodium channels in nonexcitable cells was provided by patch-clamp studies on cultured Schwann cells and astrocytes (Chiu et al., 1984; Bevan et al., 1985) , which, when held at À100 mV and then stepped to +40 mV in 10 mV steps, exhibited a family of fast-activating, fast-inactivating traces that could be blocked with the sodium-channel-specific ligands tetrodotoxin (TTX) and saxitoxin (STX). Subsequent to these early studies, a wide variety of nonexcitable cells, ranging from glial and immune cells to endothelial and cancer cells, had been shown to express voltage-gated sodium currents, and it has been shown that nonexcitable cells can express multiple sodium channel subtypes (Table 1) .
Patch-clamp recordings have confirmed the expression of functional sodium channels in cell types as divergent as astrocytes (Barres et al., 1988; , oligodendrocyte precursor cells (Sontheimer et al., 1989; Kettenmann et al., 1991; Kressin et al., 1995; Chen et al., 2008; Ká radó ttir et al., 2008) , Schwann cells (Howe and Ritchie, 1990) , fibroblasts (Estacion 1991; Li et al., 2009) , breast and prostate cancer cells (Fraser et al., 2003 (Fraser et al., ,2005 Roger et al., 2003; Brackenbury and Djamgoz, 2006; Ding et al., 2008; Gillet et al., 2009) , and macrophages and microglia (Korotzer and Cotman, 1992; Nö renberg et al., 1994; Schmidtmayer et al., 1994) , including a microglial cell line derived from the human CNS (Nicholson and Randall, 2009) . These recordings provide a precise measure of current density (and can thus be used for estimating the density of functional channels in the cell membrane) and can distinguish the expression of sodium channels that are sensitive to nanomolar levels of TTX (TTX-S; Nav1.1-Nav1.4, Nav1.6, and Nav1.7) from that of a group of TTX-resistant (TTX-R) channels, which require micromolar concentrations of TTX for blockade (Nav1.5, Nav1.8, and Nav1.9). RT-PCR, in situ hybridization, Astrocytes TTX-S, TTX-R currents; Nav1.2, Nav1.3, Nav1.5, Nav1.6 Bevan et al., 1985 Bevan et al., , 1987 Nowak et al., 1987; Barres et al., 1988; Sontheimer et al., 1991 Sontheimer et al., , 1994 Black et al., 1995a Black et al., , 1998 Black et al., , 2010 Kressin et al., 1995; Bordey and Sontheimer, 1998; Reese and Caldwell, 1999 Cancer cells Nav1.4, Nav1.5, Nav1.6, Nav1.7 Fraser et al., 2003 Fraser et al., , 2005 Roger et al., 2003; Diss et al., 2004 Diss et al., , 2005 Brackenbury and Djamgoz, 2006; Gillet et al., 2009; Yang et al., 2012 Chrondrocytes TTX-S Sugimoto et al., 1996 Dendritic cells Nav1.7 Zsiros et al., 2009; Kis-Toth et al., 2011 Endothelial cells TTX-S, TTX-R currents; Nav1.4, Nav1.5, Nav1.6 Gordienko and Tsukahara, 1994; Gosling et al., 1998; Walsh et al., 1998; Traub et al., 1999 Fibroblasts TTX-S, TTX-R; Nav1.2, Nav1.3, Nav1.5, Nav1.6, Nav1.7 Munson et al., 1979; Estacion 1991; Li et al., 2009; Chatelier et al., 2012 Keratinocytes Nav1.1, Nav1.6, Nav1.8 Zhao et al., 2008 Islet b-cells TTX-S; Nav1.2, Nav1.3 Donatsch et al., 1977; Pressel and Misler, 1991; Philipson et al., 1993; Barnett et al., 1995; Eberhardson and Grapengiesser, 1999 Macrophages TTX-S current; Nav1.5, Nav1.6 Schmidtmayer et al., 1994; Carrithers et al., 2007 Carrithers et al., , 2009 Carrithers et al., , 2011 Black et al., 2013 Microglia TTX-S current; Nav1.1, Nav1.5, Nav1.6 Korotzer and Cotman, 1992; Nö renberg et al., 1994; Craner et al., 2005; Black et al., 2009; Nicholson and Randall, 2009 Mü ller glia TTX-S, TTX-R currents; Nav1.6, Nav1.9 Chao et al., 1994; Francke et al., 1996; O'Brien et al., 2008; Linnertz et al., 2011 Odontoblasts Nav1. Red blood cells Nav1.4, Nav1.7 Hoffman et al., 2004 Schwann cells TTX-S current; Nav1.2, Nav1.3 Chiu et al., 1984; Howe and Ritchie, 1990; T lymphocytes TTX-S, TTX-R currents; Nav1.5 DeCoursey et al., 1985 DeCoursey et al., , 1987 Lai et al., 2000; Fraser et al., 2004; Lo et al., 2012 Neuron Black et al., 1998; Diss et al., 1998; Zhao et al., 2008; Zsiros et al., 2009) . Within some cell types, only a single subtype has been detected (e.g., Nav1.7 in dendritic cells; Zsiros et al., 2009) , whereas other cell types have been shown to express multiple subtypes; for instance, astrocytes have been shown to express Nav1.2, Nav1.3 (Black et al., 1995a) , Nav1.5 , and Nav1.6 (Reese and Caldwell, 1999) , and microglia have been shown to express Nav1.5 and Nav1.6 (Craner et al., 2005; Black et al., 2009) . Human red blood cells have been shown to express Nav1.4 and Nav1.7 (Hoffman et al., 2004) . Although this article focuses on the Nav1.1-Nav1.9 pore-forming a-subunits of sodium channels, there is also evidence demonstrating the presence of sodium channel b-subunits in some nonexcitable cells , where they are postulated to function as cell-adhesion molecules (Brackenbury et al., 2010) .
As described below, voltage-gated sodium channels contribute to diverse effector functions of nonexcitable cells. This is all the more remarkable because, in general, estimated densities of sodium channels in nonexcitable cells are substantially lower than those in excitable cells (<1 versus 2-75 mm À2 , respectively; see, e.g., . Spinal cord astrocytes in vitro are an exception and can express sodium channels at densities estimated to be as high as 10 channels per mm 2 , which, although not supporting action potential electrogenesis close to resting potential, can support the production of all-or-none overshooting action-potential-like responses when the cells are hyperpolarized to levels that remove resting inactivation . The density of sodium channels in cells such as astrocytes in vitro depends on the milieu to which the cells are exposed , raising the question of whether channel expression is an artifact of culture. Importantly, however, astrocytes within slices of hippocampus, cerebral cortex, spinal cord, and cerebellum also express sodium currents Chvá tal et al., 1995; Bordey and Sontheimer, 2000) . Thus, expression of these channels within astrocytes can occur within a relatively normal milieu and is not an artifact of culture. Further confirmation of this comes from immunocytochemical studies that have demonstrated the expression of sodium channels in astrocytes in situ within both the rodent ) and the human brain.
Sodium Channel Expression in Nonexcitable Cells Is Dynamic
The expression of sodium channels in nonexcitable cells is not static and, on the contrary, may change markedly depending on the developmental and/or physiological state of the cells. For instance, differentiation of cells of the oligodendrocyte lineage, from oligodendrocyte precursor cells (OPCs) to mature myelinating oligodendrocytes, is accompanied by switches in patterns of phenotypic expression (see Levine et al., 2001) , including the downregulation of sodium channels (Paez et al., 2009) . OPCs express robust voltage-sensitive sodium currents. In contrast, sodium currents are smaller and present in only a subpopulation of more differentiated O4 + cells and are absent in mature oligodendrocytes (Sontheimer et al., 1989) . The expression of sodium channels in OPCs may have important physiological consequences. It is known that action potential activity can lead to vesicular glutamate release at discrete sites along axons, and this can activate ionotropic glutamate receptors on neighboring OPCs (Kukley et al., 2007) . Eighty-one percent of OPCs that express sodium channels respond to this type of neurotransmitter release, whereas only 2% of OPCs that lack sodium channel expression show these responses, suggesting that the ability of OPCs to respond to axonal signaling may be associated with the expression of sodium channels within these cells (Ká radó ttir et al., 2008) . In fact, it has been hypothesized that the activity of these channels may trigger myelination by these cells (Ká radó ttir et al., 2008) . One possible mechanism is that expression of sodium channels in OPCs participates in setting their resting membrane potential, and this, in turn, may contribute to controlling their rate of proliferation (Xie et al., 2007) . Switches in sodium current expression are not confined to healthy nonexcitable cells but have also been reported after pathological challenge. For example, in an in vitro model of astrogliosis in which a confluent layer of cultured rat astrocytes was scratched for the production of a linear injury, the injury evoked a switch from TTX-S currents to TTX-R sodium currents (MacFarlane and Sontheimer, 1998) . Consistent with the change in sodium currents, markedly upregulated expression of the TTX-R sodium channel, Nav1.5, was recently reported in reactive astrocytes at the boundary of the scar injury in this in vitro model (Samad et al., 2013) . Importantly, upregulation of sodium channels in reactive astrocytes occurs in situ within the human brain. Observations on rapid-autopsy tissues demonstrate robust upregulation of Nav1.5, which is not seen in normal control brains, within scarring astrocytes in acute and chronic MS plaques and adjacent to cerebrovascular accidents and neoplastic lesions in the human brain  Figure 1 ).
Astrocytes are not the sole nonexcitable cell type that displays a switch in sodium channel expression after pathological insult. The differentiation of human fibroblasts into myofibroblasts under pathological conditions is accompanied by de novo Nav1.5 expression (Chatelier et al., 2012) similar to that exhibited by reactive astrocytes. Mü ller cells, the primary macroglial cells in the retina, where they provide functional and metabolic support to neighboring neurons (Bringmann and Wiedemann, 2012) , also exhibit increased sodium channel expression in response to injury (e.g., glaucoma, melanoma, retinal detachment) in that they express 4-fold larger sodium currents than do Mü ller cells from normal retinas (12.2 versus 3.0 pA/pF, respectively; Francke et al., 1996) .
Sodium Channels Participate in Multiple Effector Functions of Nonexcitable Cells
Several lines of evidence have demonstrated that sodium channels contribute to multiple, diverse cellular functions in nonexcitable cells (Table 2) . In many cases, a functional role has been demonstrated on the basis of pharmacological blockade, knockout, or knockdown. For example, Craner et al. (2005) demonstrated that sodium channel blockade with TTX attenuates phagocytosis by 40% in cultured microglia. They also showed that the phagocytic capacity of microglia derived from med mice, which lack Nav1.6 channels (Kohrman et al., 1996) , is 65% lower than that of microglia from wild-type (WT) mice. Black et al. (2009) observed that the clinically used sodium channel blocker phenytoin significantly reduces the phagocytic activity of microglia by 50%-60% (Figure 2 ). These studies also showed that TTX and phenytoin attenuate the release of the proinflammatory cytokines interleukin 1-a (IL-1a), IL-1b, and tumor necrosis factor a (TNF-a) from stimulated microglia while having minimal effects on the release of IL-2, IL-4, IL-6, IL-10, monocyte chemotactic protein 1 (MCP-1), and transforming growth factor a (TGF-a). Phenytoin and TTX also significantly decrease ATP-induced migration of microglia. Supporting a role for Nav1.6 in the pathway leading to microglial migration, the level of ATP-induced migration of microglia cultured from med mice is significantly lower than that of cells from littermate WT mice (Black et al., 2009) .
Another line of evidence of a novel contribution of sodium channels-in this case the ''cardiac'' Nav1.5 channel-to the function of nonexcitable cells was provided by Carrithers et al. (2007) , who demonstrated the expression of Nav1.5 within phagosomes of activated human macrophages by immunocytochemistry and immunogold electron microscopy ( Figure 3 ). The expression of Nav1.5 was restricted to late endosomes of these cells and was not detected in early endosomes or on the macro- 
Expression in Astrocytes within MS Tissue
A montage of gray-scale images of R. communis agglutinin I (RCA-1)-positive macrophages (white) in a section of MS tissue was constructed to provide orientation for localization of astrocytes. A region of substantial macrophage infiltration is present in the lower three-quarters of the field. An adjacent serial section was labeled for Nav1.5 (red), GFAP (green), and PLP (blue), and highmagnification images corresponding to the boxed numbers in the montage are shown in the righthand panels. A GFAP-positive astrocyte within normal-appearing white matter (NAWM), which is not in the montage field, exhibited limited Nav1.5 immunolabeling. In contrast, an astrocyte (panel 1) within white matter, which is more disrupted than NAWM, and $250 mm from the plaque border was hypertrophic and showed an upregulation of Nav1.5. Astrocytes at the border (panel 2) and within (panel 3) the active lesion displayed intense Nav1.5 immunolabeling. Colocalization of GFAP and Nav1.5 is shown in yellow. (Modified from Figure 7 in Black et al., 2010) .
phage plasma membrane. Evidence of a role for Nav1.5 in macrophage function was provided by the demonstration that TTX at 10 mM (a concentration that blocks Nav1.5) and gene knockdown of Nav1.5 with small hairpin RNA (shRNA) inhibit phagocytosis by these cells. Using timeresolved fluorometry, Carrithers et al. (2007) also demonstrated that the sodium channel activator veratridine reduces intraendosomal pH and intraendosomal [Na + ] and that 10 mM TTX blocks lipopolysaccharide-induced acidification of the intraendosomal compartment in both purified endosomes and intact macrophages. These results suggest a model in which Nav1.5 channels, located intracellularly within the membrane of late endosomes, provide a route for Na efflux, which counterbalances proton influx, and thereby maintain electroneutrality during acidification, which is one of the final stages of phagocytosis. Noting that pH regulates the current of Nav1.5 (Khan et al., 2006) , Carrithers et al. (2007) suggested that the expression and activity of Nav1.5 on the intracellular endosomal membrane may provide a regulatory loop in which, as intraendosomal pH decreases toward a functional optimum in the late endosome, the endosomal sodium channels become inactive, limit further acidification, and thus prevent cell injury. Extending these observations to human tissue, Black et al. (2013) recently demonstrated the expression of Nav1.5 in late, but not early, endosomes in phagocytosing macrophages within acute MS lesions.
Still another example of a role for sodium channels in the regulation of effector functions of nonexcitable cells is provided by dendritic cells (DCs), the antigen-presenting immune cells that function as intermediaries between innate and adaptive immunity. Immature monocyte-derived DCs express Nav1.7 channels, but the expression of these channels is attenuated during maturation (Zsiros et al., 2009 standing sodium conductance (due, for example, to persistent activation of a small fraction of available channels) would be expected to have a depolarizing effect on resting potential of these cells. A link between Nav1.7 expression and cell function in DCs is suggested by the observation that Nav1.7 current density is significantly greater in CD1a + immature DCs than in CD1a À immature DCs (Kis-Toth et al., 2011). The presence of a Nav1.7 current is associated with a depolarized resting membrane potential, as predicted by the Goldman-Hodgkin-Katz equation, in CD1a + DCs, and blockade or knockdown of Nav1.7 in these cells yields a hyperpolarization of the resting membrane potential, which is associated with attenuated mobility and gene expression of matrix metalloproteinase 12 (Kis-Toth et al., 2011). Nav1.7 blockade with TTX also attenuates inflammatory-cytokine-stimulated activation of CD1a + DCs and the release of TNF-a and IL-10 from these cells. There is also increasing evidence suggesting that levels of sodium channel expression are correlated with invasiveness and metastatic potential in several types of cancer cells. For example, strongly metastatic breast cancer cells express voltage-sensitive sodium currents, whereas weakly metastatic and normal breast epithelial cells do not (Fraser et al., 2005; Yang et al., 2012) . Upregulated expression of a neonatal splice form of Nav1.5 has been linked to strong metastatic potential in vitro and breast cancer progression, and there appears to be a correlation between Nav1.5 expression and clinically assessed lymph node invasion (Fraser et al., 2005) . Levels of sodium channel expression are also greater in prostate biopsies from patients with cancer than in non-cancer biopsies . Sodium channel activity has been reported to potentiate the effect of epidermal growth factor (EGF), which enhances the migration and invasiveness of prostate cancer cells (Uysal-Onganer and Djamgoz, 2007), suggesting a potential mechanism linking sodium channel activity to metastatic activity in these cells. In this regard, it has been demonstrated that sodium channel activity in MDA-MB-231 breast cancer cells leads to intracellular alkalinization and pericellular acidification, which promotes the activity of released proteolytic enzymes and cell invasiveness (Gillet et al., 2009) . At present, the molecular pathway(s) by which sodium channel activity participates in the regulation of intracellular and extracellular pH of cancer cells is not known, but it has been suggested to involve interactions with the sodium-proton exchanger, bicarbonate transporters, vacuolar H + -ATPase, and/or monocarboxylate transporters (Gillet et al., 2009) . Sodium channel activity is also likely to affect cancer cells' membrane potential, which has been linked to their proliferation and migration (Yang and Brackenbury, 2013) . In in vitro assays of cancer cell invasiveness, blockade, or knockdown of sodium channels with TTX, phenytoin or small interfering RNA (siRNA) has been shown to significantly attenuate directional motility and cell migration (Roger et al., 2003; Fraser et al., 2005; Brackenbury et al., 2007; Brackenbury, 2012; Yang et al., 2012) . At the in vivo level, it has been reported in a rat model of prostate cancer that blocking sodium channel activity with TTX reduces the number of lung metastases by 40% and significantly prolongs lifespan (Yildirim et al., 2012) . Whether targeted sodium channel blockade or knockdown can contribute to cancer treatment is not yet known, but higher levels in more metastatic cells suggest these channels as potential biomarkers . Sontheimer et al., 1994 Cancer cells TTX, phenytoin, Nav1.5 siRNA: attenuate motility, migration, invasiveness, metastasis, and extracellular acidification Fraser et al., 2003 Fraser et al., , 2005 Roger et al., 2003; Brackenbury et al., 2007; Brackenbury and Djamgoz, 2006; Gillet et al., 2009; Yang et al., 2012; Yildirim et al., 2012 Dendritic Pathways of Sodium Channel Activity Regulating Cell Function Although it is clear that sodium channels participate in or regulate multiple functions within a spectrum of nonexcitable cell types, we presently have only hints about the underlying molecular mechanism(s). Extrapolating from the small number of cell types in which mechanisms linking sodium channels to cell function have been studied, it seems likely, in fact, that sodium channels affect physiological responses of cells by multiple pathways (Figure 4) . In a study on astrocytes, Sontheimer et al. (1994) suggested a mechanism in which sodium channels provide a route for a small sustained Na + influx, which is necessary for continued operation of Na + /K + -ATPase. In these cells, sodium channel blockade with TTX attenuates Na + /K + -ATPase activity, reduces astrocyte [Na + ] I , and with prolonged exposure, leads to cell death. This cascade, in which voltage-gated channels provide a route for Na + ion influx, which is required for maintaining [Na + ] i at concentrations necessary for activity of the sodium pump, suggests that the flux of Na + ions through sodium channels may provide a feedback loop that, in turn, modulates the ability of astrocytes to regulate K + levels in the extracellular space. It is not yet known whether sodium channels contribute to the regulation of Na + /K + -ATPase activity in a similar manner in other cell types. Observations on T lymphocytes suggest that sodium channel activity can trigger calcium signals, which, in turn, fine-tune the effector functions of these cells. Sustained Ca 2+ influx has been shown to be required for the positive selection of CD4 + CD8 + T cells (Oh-hora, 2009) . Recent work has demonstrated the presence of Nav1.5 sodium channels in these cells and has shown that blockade of these sodium channels with TTX, or knockdown with shRNA, inhibits the induction of sustained Ca 2+ influx induced in CD4 + CD8 + thymocytes by the positively selecting ligand (gp250-I-E K ) and prevents the positive selection of CD4 + T cells (Lo et al., 2012) . Moreover, a gain-offunction assay showed that ectopic expression of Nav1.5 channels in T cells obtained from mice with the transgenic expression of a receptor specific to moth cytochrome c bound to major histocompatibility complex (MHC) class II molecule I-E K (Lo et al., 2009 ) (these mice do not normally express Nav1.5) endows these cells with an ability to respond appropriately to positively selecting ligands, to which these cells do not normally respond (Lo et al., 2012) . Sodium channel activity thus appears to contribute to Ca 2+ influx after stimulation in these T cells and thereby play a critical role in positive selection after challenge by weak-signal ligands. How the Nav1.5 channels function within these cells to trigger calcium signals is not yet known.
A role for sodium channels as a driver of reverse (Ca 2+ -importing) Na/Ca exchange, which has been observed in multiple nonexcitable cell types, including NG2 cells and astrocytes (Kirischuk et al., 1997; Paluzzi et al., 2007; Tong et al., 2009) , is beginning to emerge as a common motif. The Na/Ca exchanger can operate in forward mode by carrying Na + ions down their concentration gradient into cells and in return exporting Ca 2+ or, if the cell is depolarized or the transmembrane gradient of Na + is reduced, can function in reverse mode by carrying Na + ions out of the cell while importing Ca 2+ (Annunziato et al., 2004) . In NG2 cells, which are sometimes referred to as oligodendrocyte precursors cells, Tong et al. (2009) demonstrated increased intracellular Na + and Ca 2+ levels, coincident with membrane depolarization and enhanced migratory capacity of the cells, that could be evoked by the application of GABA. Blockade or knockdown of sodium channels by siRNA significantly decreased the rise in [Ca 2+ ] i and [Na + ] i , and attenuated the migration of NG2 cells (Tong et al., 2009) . Attenuated [Ca 2+ ] i and reduced cell migration were also observed after siRNA knockdown of the Na/Ca exchanger or KB-R7943 blockade of reverse Na/Ca exchange. Thus, within NG2 cells, Na + flux through sodium channels, in this case triggered by GABA, elicits reverse operation of the Na/Ca exchanger and influx of Ca 2+ , resulting in increased [Ca 2+ ] i affecting cellular motility. A similar mechanism may operate in astrocytes. Although astrocytes do not generate action potentials under physiological conditions and have thus been considered to be electrically inexcitable, Verkhratsky and Kettenmann (1996) noting that these cells can produce transient Ca 2+ signals, which can propagate as waves-have used the term ''Ca 2+ excitability'' to describe this phenomenon. Both forward and reverse operation of the Na/Ca exchanger have been described in astrocytes (Kirischuk et al., 1997; Paluzzi et al., 2007) , which, as a result of , are poised close to the reversal potential of the Na/Ca exchanger, which can therefore produce rapid, short-lived, and spatially restricted Ca 2+ signals (Kirischuk et al., 2012) . The possibility that activity of sodium channels can elicit reverse Na/Ca exchange and modify cellular responses in astrocytes, and in other cell types, is currently being examined. A different role for sodium channels in the modulation of cell motility is suggested by the intracellular localization of Nav1.6 near F-actin bundles in macrophages and melanoma cells in areas of cell attachment, where a Nav1.6 splice variant regulates cellular invasion via modulation of the formation of podosomes (specialized F-actin zones, which mediate adhesion, invasion, and migration) and invadopodia (Carrithers et al., 2009) . Sodium channel blockade with 0.3 mM TTX and Nav1.6 knockdown with shRNA inhibit podosome formation and invasion through the basement membrane matrix. Further implicating Nav1.6, podosome formation was also attenuated in macrophages obtained from med mice. Activation of sodium channels with veratridine triggered a shift of Na + from cationic vesicular compartments to mitochondria and a rise in intracellular Ca 2+ in macrophages, and blockade of the mitochondrial Na/Ca exchanger significantly reduced the veratridine-induced increase in [Ca 2+ ] I within wildtype macrophages, but not in macrophages from med mice. Taken together, these observations suggest that Nav1.6 contributes-via a mechanism involving release of sodium from vesicular intracellular stores, uptake by mitochondria, and extrusion of Ca 2+ from mitochondria-to the control of podosome and invadopodia formation and thereby regulates F-actin cytoskeletal remodeling and movement of macrophages and melanoma cells. An added layer of complexity may arise from the fact that sodium channels possess alternative splicing sites, many of which are evolutionarily conserved and probably functionally important (e.g., Plummer et al., 1997; Diss et al., 2004; Gazina et al., 2010; Schroeter et al., 2010) . The splice variants can have distinct biophysical properties, which in some cases are dependent on interactions with b-subunits (Farmer et al., 2012) . Neonatal splice variants of sodium channels have been detected in multiple nonexcitable cells, including astrocytes (Oh and Waxman, 1998) , human macrophages (Carrithers et al., 2009) , and cancer cells (Fraser et al., 2005; Brackenbury et al., 2007) . Although the functional consequences of expression of these splice variants is not fully understood, it is known that expression of the Nav1.5 neonatal splice variant potentiates the invasiveness of breast cancer cells (Brackenbury et al., 2007) . Interestingly, alternative splicing of some sodium channels, such as Nav1.6, can produce truncated and presumably nonconducting two-domain proteins, which are present in a broad range of nonneuronal tissues (Plummer et al., 1997; Oh and Waxman, 1998) . It can also be speculated that further study will uncover nonconducting roles for sodium channels, as has been proposed for the autoregulation of transcription by the C terminus of the L-type calcium channel Cav1.2 (Dolmetsch et al., 2001; Gomez-Ospina et al., 2006; Satin et al., 2011) and tumor progression by the potassium channel ether-á -go-go (Kv10.1) (Downie et al., 2008) .
Perspectives: An Opportunity for Neuroscientists
It is now clear that many cell types traditionally considered nonexcitable express voltage-gated sodium channels. Moreover, there is abundant evidence that blockade or knockdown of sodium channel activity can significantly alter effector functions and physiological responses of these nonexcitable cells. We do not, at this time, have a full appreciation of the intracellular cascades by which sodium channel activity contributes to signaling pathways in nonexcitable cells. Data from recent studies suggest that there are multiple intracellular molecular mechanisms and provide hints that sodium channel activity in some cells may amplify, localize, and/or fine-tune intracellular Ca 2+ levels.
These studies also indicate that, in at least some cell types, the activity of sodium channels localized within intracellular compartments, and not solely on the plasma membrane, can participate in regulation of cellular functions. Contributions of voltage-gated sodium channels to the function of nonexcitable cells should not be a surprise to neuroscientists. As a result of their voltage dependence and kinetics, several sodium channels, notably Nav1.9 (Cummins 
coli in Activated Macrophages
Sixty minutes after bacterial challenge, Nav1.5 (green) and Texas-Red-labeled E. coli were colocalized in a perinuclear region. The nucleus was stained with DAPI (blue). (Modified from Figure 6B in Carrithers et al., 2007). et al., 1999) and Nav1.7 (Cummins et al., 1998) , participate in electrogenesis in the subthreshold range, where they amplify small depolarizations so as to bring the cell to the actionpotential threshold where other sodium channel subtypes activate to produce the majority of the inward current responsible for the depolarizing phase of the action potential. Within the injured nervous system, persistent sodium currents, even in resting axons, can trigger injurious Ca 2+ -importing reverse Na/Ca exchange (Stys et al., 1992 (Stys et al., , 1993 . However, in contrast to the roles played by sodium channels in the subthreshold domain in excitable cells (see Rush et al., 2007 for a review), the noncanonical roles of sodium channels, in cell types traditionally viewed as nonexcitable, have been relatively unexplored.
There is a world of sodium channel activity, within cells traditionally viewed as nonexcitable, that has been ''below the surface'' to neuroscientists. Some of the unanswered questions about the noncanonical roles of sodium channels are summarized in Table 3 . We need to know the full array of cell types in which sodium channels are expressed and the full spectrum of the functional roles of sodium channels in these cells. There is a pressing need to understand the mechanisms by which sodium channels exert their influences in these cells. It is clear, from the roles of sodium channels in phagocytosis and their upregulation in glial cells in the injured nervous system, that these channels are poised to contribute to disease pathophysiology, but their precise contributions to the functions of these, as well as other, cell types in disease remains to be elucidated. Finally, given that sodium channels are emerging as functional players in nonexcitable cells in disease states, we need to understand whether targeted blockade or knockdown of sodium channel subtypes in specific cell types might be of therapeutic value. Neuroscientists, armed with an array of methods for directly monitoring channel activity by using electrophysiological, imaging, or pharmacological techniques and with assays that permit real-time assessment of intracellular [Na + ] and [Ca 2+ ], are in a unique position to further elucidate the noncanonical roles of voltage-gated sodium channels in cells that have traditionally been considered nonexcitable. Many of these cell types interact, directly or indirectly, with neurons. We predict that over the next decade, neuroscientists will use tools already at their disposal to expand our understanding of the ensemble of sodium-channelmediated mechanisms that contribute to the function of normal and injured cells. 
